tradmap

NMTC Earnings NEUROONE MEDICAL TECHNOLOGIES Corp

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$0 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $5M $9M 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$14M -$7M $0 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 $0 Q4 '22 Q2 '23 Q1 '24 Q4 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $2M $3M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$3M -$782637 $2M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–21 of 21
Q3 20262026-06-30-0.752026-08-1310-Q
Q2 20262026-03-31-0.442026-05-1210-Q
Q1 20262025-12-31-0.032026-02-1710-Q
FY 20252025-09-30-0.092025-12-1710-K
Q3 20262025-06-30-0.322026-08-1310-Q
Q2 20262025-03-31-0.092026-05-1210-Q
Q1 20262024-12-310.062026-02-1710-Q
FY 20252024-09-30-0.462025-12-1710-K
Q3 20252024-06-30-0.352025-08-1410-Q
Q2 20252024-03-31-0.252025-05-1310-Q
Q1 20252023-12-31-0.142025-02-1210-Q
FY 20242023-09-30-0.652024-12-1710-K
Q3 20242023-06-30-0.522024-08-1410-Q
Q2 20242023-03-31-0.322024-05-1410-Q
Q1 20242022-12-31-0.112024-02-1310-Q
FY 20232022-09-30-0.632023-12-1510-K
Q3 20232022-06-30-0.542023-08-1410-Q
Q2 20232022-03-31-0.372023-05-1210-Q
Q1 20232021-12-31-0.182023-02-1310-Q
FY 20222021-09-30-0.932022-12-2210-K
Q3 20222021-06-30-0.712022-08-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.